Beutel, Goodman & CO Ltd. Novo Nordisk A S Transaction History
Beutel, Goodman & CO Ltd.
- $17.4 Billion
- Q1 2025
A detailed history of Beutel, Goodman & CO Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Beutel, Goodman & CO Ltd. holds 79,163 shares of NVO stock, worth $5.31 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
79,163
Previous 79,163
-0.0%
Holding current value
$5.31 Million
Previous $11.3 Million
51.39%
% of portfolio
0.03%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
329MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.26 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$991 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$830 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$826 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$796 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $151B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...